Showing results (31-40 of 121) with videos related to

Sort By:
Pageof 13
International Journal of Pediatric Otorhinolaryngology|September 19, 2019
Age-related causes of emergency department visits after pediatric adenotonsillectomy at a tertiary pediatric referral centerNathan R Lindquist, Zipei Feng, Ankita Patro, et al.
European Journal of Biochemistry|February 14, 1998
Cell adhesion properties of hemolin, an insect immune protein in the Ig superfamilyR Bettencourt, H Lanz-Mendoza, K R Lindquist, et al.
Ear, Nose, & Throat Journal|April 26, 2019
Evaluating Simulator-Based Teaching Methods for Endoscopic Sinus SurgeryNathan R Lindquist, Matthew Leach, Matthew C Simpson, et al.
The Journals of Gerontology. Series B, Psychological Sciences and Social Sciences|January 1, 1995
Optical flow, spatial orientation, and the control of posture in the elderlyM G Wade, R Lindquist, J R Taylor, et al.
American Journal of Surgery|November 1, 1995
Enhanced tumor cell expression of tumor necrosis factor receptors in head and neck squamous cell carcinomaS E von Biberstein, J D Spiro, R Lindquist, et al.
Otology & Neurotology : Official Publication of the American Otological Society, American Neurotology Society [And] European Academy of Otology and Neurotology|December 19, 2019
The Role of Obesity in Iatrogenic Encephaloceles of the Temporal BoneNathan R Lindquist, Eric N Appelbaum, Alex D Sweeney, et al.
Archives of Otolaryngology--Head & Neck Surgery|July 1, 1996
Interleukin-1 receptor antagonist in head and neck squamous cell carcinomaS E von Biberstein, J D Spiro, R Lindquist, et al.
Cellular Immunology|June 11, 1991
Cytotoxic T lymphocyte (CTL)-mediated cytolysis proceeds in the absence of Na+/H+ antiport activity: regulation of cytosolic pH by the Na+/H+ antiport in a cloned CTLT K Howcroft, L M Loew, E J Cragoe, et al.
The Journal of Rheumatology|March 28, 1998
Uveitis and central nervous system vasculitisJ T Rosenbaum, S Roman-Goldstein, G R Lindquist, et al.
Biochemical and Biophysical Research Communications|August 15, 1988
Protein kinase C (PKC) inhibitors inhibit primary (1-0) but not secondary (1-1) or cloned cytotoxic T lymphocytesT K Howcroft, S M Tatum, J M Cosgrove, et al.
Pageof 13